Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 13118 [2017-04622]
Download as PDF
13118
Federal Register / Vol. 82, No. 45 / Thursday, March 9, 2017 / Notices
related to this announcement is
identified in Unit I. under
SUPPLEMENTARY INFORMATION.
FOR FURTHER INFORMATION CONTACT:
For technical information contact:
John Schaeffer, Chemical Control
Division (7405M), Office of Pollution
Prevention and Toxics, Environmental
Protection Agency, 1200 Pennsylvania
Ave. NW., Washington, DC 20460–0001;
telephone number: (202) 564–8173;
email address: schaeffer.john@epa.gov.
For general information contact: The
TSCA-Hotline, ABVI-Goodwill, 422
South Clinton Ave., Rochester, NY
14620; telephone number: (202) 554–
1404; email address: TSCA-Hotline@
epa.gov.
SUPPLEMENTARY INFORMATION:
I. Chemical Substances and/or Mixtures
Information received about the
following chemical substances and/or
mixtures is provided in Unit IV.:
A. Acetaldehyde (CASRN 75–07–0).
B. D-erythro-hex-2-enonic acid,
gamma.-lactone, monosodium salt.
(CASRN 6381–77–7).
II. Authority
Section 4(d) of TSCA (15 U.S.C.
2603(d)) requires EPA to publish a
notice in the Federal Register reporting
the receipt of information submitted
pursuant to a rule, order, or consent
agreement promulgated under TSCA
section 4 (15 U.S.C. 2603).
asabaliauskas on DSK3SPTVN1PROD with NOTICES
III. Docket Information
A docket, identified by the docket
identification (ID) number EPA–HQ–
OPPT–2013–0677, has been established
for this Federal Register document,
which announces the receipt of the
information. Upon EPA’s completion of
its quality assurance review, the
information received will be added to
the docket identified in Unit IV., which
represents the docket used for the TSCA
section 4 rule, order, and/or consent
agreement. In addition, once completed,
EPA reviews of the information received
will be added to the same docket. Use
the docket ID number provided in Unit
IV. to access the information received
and any available EPA review.
EPA’s dockets are available
electronically at https://
www.regulations.gov or in person at the
Office of Pollution Prevention and
Toxics Docket (OPPT Docket),
Environmental Protection Agency
Docket Center (EPA/DC), West William
Jefferson Clinton Bldg., Rm. 3334, 1301
Constitution Ave. NW., Washington,
DC. The Public Reading Room is open
from 8:30 a.m. to 4:30 p.m., Monday
through Friday, excluding legal
VerDate Sep<11>2014
17:43 Mar 08, 2017
Jkt 241001
holidays. The telephone number for the
Public Reading Room is (202) 566–1744,
and the telephone number for the OPPT
Docket is (202) 566–0280. Please review
the visitor instructions and additional
information about the docket available
at https://www.epa.gov/dockets.
IV. Information Received
As specified by TSCA section 4(d),
this unit identifies the information
received by EPA.
A. Acetaldehyde (CASRN 75–07–0).
1. Chemical Uses: Acetaldehyde is
used as an intermediate in the
manufacture of many products,
including pyridines, acetate esters,
pentaerythritol, peracetic acid, 1,3butylene glycol (1,3-Butanediol), and
acetic acid.
2. Applicable Rule, Order, or Consent
Agreement: Chemical testing
requirements for second group of high
production volume chemicals (HPV2),
40 CFR 799.5087.
3. Applicable docket ID number: The
information received will be added to
docket ID number EPA–HQ–OPPT–
2007–0531.
4. Information Received: EPA
received the following information:
Request for exemption from testing
requirements.
B. D-erythro-hex-2-enonic acid,
gamma.-lactone, monosodium salt.
(CASRN 6381–77–7).
1. Chemical Uses: D-erythro-hex-2enonic acid, gamma.-lactone,
monosodium salt is used as an
antioxidant in food applications for
which the vitamin activity of ascorbic
acid (Vitamin C) is not required.
Specifically, the compound is most
frequently used to develop and retain
the coloring and taste in meat products.
It is also used for seafood products,
fruit, and vegetable preservation, in
beverages, and as a developing agent in
photographic applications.
2. Applicable Rule, Order, or Consent
Agreement: Chemical testing
requirements for second group of high
production volume chemicals (HPV2),
40 CFR 799.5087.
3. Applicable docket ID number: The
information received will be added to
docket ID number EPA–HQ–OPPT–
2007–0531.
4. Information Received: EPA
received the following information:
Request for exemption from testing
requirements.
Authority: 15 U.S.C. 2601 et seq.
PO 00000
Frm 00030
Fmt 4703
Sfmt 9990
Dated: February 15, 2017.
Maria J. Doa,
Director, Chemical Control Division, Office
of Pollution Prevention and Toxics.
[FR Doc. 2017–04697 Filed 3–8–17; 8:45 am]
BILLING CODE 6560–50–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting for the initial
review of applications in response to
Funding Opportunity Announcement
(FOA), RFA–CE–17–001, Research
Using Linked Data to Understand Motor
Vehicle Injury Among Older Adults.
Time and Date: 9:00 a.m.–5:00 p.m.,
EDT, April 11, 2017 (Closed).
Place: Teleconference.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters for Discussion: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘Research Using Linked Data to
Understand Motor Vehicle Injury
Among Older Adults’’, FOA RFA–CE–
17–001.
Contact Person for More Information:
Kimberly Leeks, Ph.D., M.P.H.,
Scientific Review Officer, CDC, 4770
Buford Highway NE., Mailstop F78,
Atlanta, Georgia 30341–3717,
Telephone: (770) 488–5964.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2017–04622 Filed 3–8–17; 8:45 am]
BILLING CODE 4163–18–P
E:\FR\FM\09MRN1.SGM
09MRN1
Agencies
[Federal Register Volume 82, Number 45 (Thursday, March 9, 2017)]
[Notices]
[Page 13118]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-04622]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): Initial Review
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces a meeting for the initial review of
applications in response to Funding Opportunity Announcement (FOA),
RFA-CE-17-001, Research Using Linked Data to Understand Motor Vehicle
Injury Among Older Adults.
Time and Date: 9:00 a.m.-5:00 p.m., EDT, April 11, 2017 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the public in accordance with
provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director, Management Analysis and Services
Office, CDC, pursuant to Public Law 92-463.
Matters for Discussion: The meeting will include the initial
review, discussion, and evaluation of applications received in response
to ``Research Using Linked Data to Understand Motor Vehicle Injury
Among Older Adults'', FOA RFA-CE-17-001.
Contact Person for More Information: Kimberly Leeks, Ph.D., M.P.H.,
Scientific Review Officer, CDC, 4770 Buford Highway NE., Mailstop F78,
Atlanta, Georgia 30341-3717, Telephone: (770) 488-5964.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2017-04622 Filed 3-8-17; 8:45 am]
BILLING CODE 4163-18-P